Real-World Ibrexafungerp Use Patterns Among Patients with Commercial Health Insurance, United States, 2021–2023
Authors
- Dallas J. Smith (ORCID: https://orcid.org/0000-0001-5707-528X)
- Kaitlin Benedict (ORCID: https://orcid.org/0000-0003-0458-2493)
- Jeremy A.W. Gold (ORCID: https://orcid.org/0000-0002-5054-7616)
Institutions
- National Center for Emerging and Zoonotic Infectious Diseases (US)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-08-16
- DOI
- https://doi.org/10.1007/s40801-025-00513-x
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00